Angiotensin Receptor Blockers in Aortic Stenosis

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 144 participants.

Also called NCT04913870

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 144 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04913870
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada, Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04913870. Randomized; quadruple masking; primary purpose treatment. Start 2020-02-01 (actual); primary completion 2027-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Angiotensin Receptor Blockers in Aortic Stenosis
Acronym
ARBAS
Condition
Aortic Stenosis
Condition
Aortic Valve Stenosis
Intervention (Other)
Placebo
Lead sponsor
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval (class: other)
Collaborator
Odense University Hospital (class: other)

Record details

Record id
cardio:ct-nct04913870
Content hash
82b3e7fe735bad4820a2d028d9f4eca83a3b0bc7dd0038b1c5d3a9b0e3b7c6ae